Search

Author/Creator Ardeshna, Kirit M.

1. A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). (February 2016)

Authors:
Flinn, Ian W.; Bartlett, Nancy L.; Blum, Kristie A.; Ardeshna, Kirit M.; LaCasce, Ann S.; Flowers, Christopher R.; Shustov, Andrei R.; Thress, Kenneth S.; Mitchell, Patrick; Zheng, Fred; Skolnik, Jeffrey M.; Friedberg, Jonathan W.
Journal:
European journal of cancer
Issue:
Volume 54(2016)
Page Start:
11
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). (February 2016)

Authors:
Flinn, Ian W.; Bartlett, Nancy L.; Blum, Kristie A.; Ardeshna, Kirit M.; LaCasce, Ann S.; Flowers, Christopher R.; Shustov, Andrei R.; Thress, Kenneth S.; Mitchell, Patrick; Zheng, Fred; Skolnik, Jeffrey M.; Friedberg, Jonathan W.
Journal:
European journal of cancer
Issue:
Volume 54(2016)
Page Start:
11
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy. (15th May 2015)

Authors:
Alwan, Ferras; He, Annie; Montoto, Silvia; Kassam, Shireen; Mee, Matthew; Burns, Fiona; Edwards, Simon; Wilson, Andrew; Tenant-Flowers, Melinda; Marcus, Robert; Ardeshna, Kirit M.; Bower, Mark; Cwynarski, Kate
Journal:
AIDS
Issue:
Volume 29:Number 8(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy. (15th May 2015)

Authors:
Alwan, Ferras; He, Annie; Montoto, Silvia; Kassam, Shireen; Mee, Matthew; Burns, Fiona; Edwards, Simon; Wilson, Andrew; Tenant-Flowers, Melinda; Marcus, Robert; Ardeshna, Kirit M.; Bower, Mark; Cwynarski, Kate
Journal:
AIDS
Issue:
Volume 29:Number 8(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposure. (18th January 2014)

Authors:
Kothari, Jaimal; Peggs, Karl S.; Bird, Antonia; Thomson, Kirsty J.; Morris, Emma; Virchis, Andres E.; Lambert, Jonathan; Goldstone, Anthony H.; Linch, David C.; Ardeshna, Kirit M.
Journal:
British journal of haematology
Issue:
Volume 165:Number 3(2014:May)
Page Start:
334
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Autologous stem cell transplantation outcomes in elderly patients with B cell Non‐Hodgkin Lymphoma. (26th June 2015)

Authors:
Gohil, Satyen H.; Ardeshna, Kirit M.; Lambert, Jonathan M.; Pule, Martin A.; Mohamedbhai, Sajir; Virchis, Andres; Morris, Emma C.; Linch, David C.; Thomson, Kirsty J.; Peggs, Karl S.
Journal:
British journal of haematology
Issue:
Volume 171:Number 2(2015:Oct.)
Page Start:
197
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Central nervous system prophylaxis in patients with diffuse large B cell lymphoma, are we treating ourselves? A response to the recent BCSH Guideline – response to Griffin et al. (7th July 2014)

Authors:
McMillan, Andrew; Ardeshna, Kirit M.; Cwynarski, Kate; Lyttelton, Matthew; McKay, Pam; Montoto, Silvia
Journal:
British journal of haematology
Issue:
Volume 167:Number 4(2014:Nov.)
Page Start:
579
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Clinical outcomes and risk factors for severe COVID‐19 in patients with haematological disorders receiving chemo‐ or immunotherapy. (12th August 2020)

Authors:
Fox, Thomas A.; Troy‐Barnes, Ethan; Kirkwood, Amy A.; Chan, Wei Yee; Day, James W.; Chavda, Selina J.; Kumar, Emil A.; David, Kate; Tomkins, Oliver; Sanchez, Emilie; Scully, Marie; Khwaja, Asim; Lambert, Jonathan; Singer, Mervyn; Roddie, Claire; Morris, Emma C.; Yong, Kwee L.; Thomson, Kirsty J.;...
Journal:
British journal of haematology
Issue:
Volume 191:Number 2(2020)
Page Start:
194
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗